Answer to Question 1
Correct Answer: 3
Rationale 1: Tamoxifen does not inhibit the metabolism of breast cancer cells.
Rationale 2: Tamoxifen does not inhibit the cellular mitosis of breast cancer.
Rationale 3: Tamoxifen acts by blocking estrogen receptors.
Rationale 4: Tamoxifen does not bind to the DNA of breast cancer cells.
Global Rationale: Tamoxifen works by blocking estrogen receptors on breast tissue. It does not inhibit the metabolism, inhibit cellular mitosis or bind to the DNA of breast cancer cells.
Answer to Question 2
Correct Answer: 4
Rationale 1: They are not cytotoxic.
Rationale 2: They block substances essential for hormone growth.
Rationale 3: They produce few debilitating adverse effects that other antineoplastics produce.
Rationale 4: This classification of medications can produce debilitating adverse effects when given at high doses for prolonged periods of time.
Global Rationale: In general, the hormones and hormone antagonists act by blocking the substances essential for tumor growth. Because these drugs are not cytotoxic, they produce few of the life-threatening toxic effects of antineoplastics from other classes. They can, however, produce significant adverse effects when given at high doses for prolonged periods.
The nurse uses a noninvasive bladder ultrasound to measure the client’s bladder volume.
Medicine Vector Icon
Breast-Feeding Mothers Have Increased Nutrient Needs
A multistep model for colon cancer. The first mutation, in the APC gene, leads to the formation of p
Genomic sequencing has identified hundreds of mutations in many classes of genes in both breast canc